share_log

Leerink Partners Initiates Coverage On Tenaya Therapeutics With Outperform Rating, Announces Price Target of $7

Benzinga ·  Nov 30, 2023 08:46

Leerink Partners analyst Mani Foroohar initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Outperform rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment